National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines: Clinical Utilization of Cardiac Biomarker Testing in Heart Failure

This publication has 138 references indexed in Scilit:

• Relation between cardiac troponin I and mortality in acute decompensated heart failure
  American Heart Journal, 2007
• N-Terminal Fragment of the Prohormone Brain-Type Natriuretic Peptide (NT-proBNP), Cardiovascular Events, and Mortality in Patients With Stable Coronary Heart Disease
  JAMA, 2007
• Influence of history of heart failure on diagnostic performance and utility of B-type natriuretic peptide testing for acute dyspnea in the emergency department
  American Heart Journal, 2006
• Serial testing of B-type natriuretic peptide and NTpro-BNP for monitoring therapy of heart failure: The role of biologic variation in the interpretation of results
  American Heart Journal, 2006
• Management of elderly patients with congestive heart failure—Design of the Trial of Intensified versus standard Medical therapy in Elderly patients with Congestive Heart Failure (TIME-CHF)
  American Heart Journal, 2006
• Low prevalence of B-type natriuretic peptide levels <100 pg/mL in patients with heart failure at hospital discharge
  American Heart Journal, 2006
• Gray zone BNP levels in heart failure patients in the emergency department: Results from the Rapid Emergency Department Heart Failure Outpatient Trial (REDHOT) multicenter study
  American Heart Journal, 2006
• Amino-Terminal Pro-B-Type Natriuretic Peptide and B-Type Natriuretic Peptide in the General Community
  Journal of the American College of Cardiology, 2006
• Relationship between anemia, cardiac troponin I, and B-type natriuretic peptide levels and mortality in patients with advanced heart failure
  American Heart Journal, 2005
• Retrospective analysis of thecost-effectiveness of using plasmabrain natriuretic peptide inscreening for left ventricularsystolic dysfunction in the general population
  Journal of the American College of Cardiology, 2003